Accelerated drug-testing platform for ALS paves way for therapeutic innovation
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
CNET on MSN2d
ExpressVPN Rolls Out Major Upgrade to Its Already Impressive Lightway Protocol
By recoding its Lightway protocol in Rust, ExpressVPN claims it has beefed up its speed, security and performance.
Federal cap on health grants could cost Iowa universities, colleges millions
The National Institutes of Health announced it would cap "Facilities and Administrative" costs at 15% for new and existing grants.
Yes, Australia needs new homes—but they must be built to withstand disasters in a warmer world
Australia's housing crisis has created a push for fast-tracked construction. Federal, state and territory governments have set a target of 1.2 million new homes over five years.
Politico Europe7h
Russian hackers find ways to snoop on Ukrainian Signal accounts
Phones found on the battlefield are being linked to Moscow’s intelligence services systems for spying, Google finds.
ExpressVPN's Aircove router doubles its speeds with new update
ExpressVPN is one of the fastest VPNs we've tested, and Aircove's speeds get a huge boost in this update. AircoveOS v5 can ...
News Medical on MSN2d
Groundbreaking ALS platform trial accelerates research and drug testing
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...
RS-NEWS6d
Microsoft Plans to Switch Off Kerberos PAC Validation Protocols by April 2025
Microsoft has officially begun the countdown to shutting down its Kerberos PAC Validation Protocols for Windows 10, Windows ...
The Daily Signal6d
Trump Should Reinstate Obama’s Moratorium on Risky Biological Research
Donald Trump is preparing an executive order to halt funding of gain-of-function research—lab experimentation designed to ...
The Protocol: Can Based Rollups Solve Ethereum’s Layer-2 Problem?
Welcome to The Protocol, CoinDesk's weekly wrap-up of the most important stories in cryptocurrency tech development. I'm Ben Schiller, CoinDesk’s ...
Anixa Biosciences, Inc.: Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ ...